56 phenotypes from 6 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Hbegftm1.1Mek/Hbegf+ B6.Cg-Hbegftm1.1Mek	abnormal cardiovascular system physiology	J:161948
Hbegftm1.1Mek/Hbegf+ involves: C57BL/6 * C57BL/6J * CBA	no abnormal phenotype detected	J:82728
Hbegftm1.1Mek/Hbegftm1.1Mek B6.Cg-Hbegftm1.1Mek	abnormal atrioventricular valve morphology	J:161948
	abnormal cardiovascular system physiology	J:161948
	abnormal heart ventricle outflow tract morphology	J:161948
Hbegftm1.1Mek/Hbegftm1.1Mek involves: C57BL/6 * C57BL/6J * CBA	abnormal atrioventricular valve morphology	J:82728
	abnormal semilunar valve morphology	J:82728
	decreased ventricle muscle contractility	J:82728
	dilated heart left ventricle	J:82728
	dilated heart right ventricle	J:82728
	dilated heart ventricle	J:82728
	enlarged aortic valve	J:82728
	enlarged atrioventricular valve	J:82728
	enlarged heart	J:82728
	enlarged mitral valve	J:82728
	enlarged pulmonary valve	J:82728
	enlarged semilunar valve	J:82728
	enlarged tricuspid valve	J:82728
	increased myocardial fiber size	J:82728
	postnatal lethality, incomplete penetrance	J:82728
	premature death	J:82728
	thick aortic valve	J:82728
	thick mitral valve	J:82728
	thick pulmonary valve	J:82728
	thick tricuspid valve	J:82728
Hbegftm1Dcl/Hbegftm1Dcl involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal atrioventricular valve development	J:83820
	abnormal pulmonary alveolus morphology	J:83820
	abnormal pulmonary valve development	J:83820
	abnormal type II pneumocyte morphology	J:83820
	aortic valve stenosis	J:83820
	atrioventricular valve stenosis	J:83820
	decreased ventricle muscle contractility	J:83820
	dilated aorta	J:83820
	ectopic cartilage	J:83820
	enlarged aortic valve	J:83820
	enlarged atrioventricular valve	J:83820
	enlarged heart	J:83820
	enlarged pulmonary valve	J:83820
	enlarged semilunar valve	J:83820
	impaired lung alveolus development	J:83820
	increased heart weight	J:83820
	postnatal lethality	J:83820
	premature death	J:83820
	pulmonary hypoplasia	J:83820
	pulmonary valve stenosis	J:83820
	semilunar valve stenosis	J:83820
Hbegftm1Hhar/Hbegftm1Hhar Tg(Six3-cre)69Frty/0 involves: C57BL/6 * CBA * DBA/2	abnormal behavioral response to xenobiotic	J:154094
	abnormal cerebral cortex pyramidal cell morphology	J:154094
	abnormal social investigation	J:154094
	abnormal spatial reference memory	J:154094
	decreased prepulse inhibition	J:154094
	hyperactivity	J:154094
	increased locomotor activity	J:154094
Hbegftm1Mek/Hbegftm1Mek involves: C57BL/6 * C57BL/6J * CBA	no abnormal phenotype detected	J:82728
Hbegftm2Mek/Hbegftm2Mek B6.Cg-Hbegftm2Mek	abnormal atrioventricular valve morphology	J:161948
	abnormal heart ventricle outflow tract morphology	J:161948
Hbegftm2Mek/Hbegftm2Mek involves: 129/Sv * C57BL/6 * CBA	abnormal cardiovascular system morphology	J:86547
	abnormal cardiovascular system physiology	J:86547
	abnormal heart size	J:86547
	abnormal heart valve morphology	J:86547
	cardiac fibrosis	J:86547
	decreased cardiac muscle contractility	J:86547
	dilated cardiomyopathy	J:86547
	enlarged atrioventricular valve	J:86547
	enlarged heart	J:86547
	enlarged semilunar valve	J:86547
	premature death	J:86547
	thin myocardium	J:86547
Hbegftm3Mek/Hbegf+ involves: 129/Sv * C57BL/6 * CBA	abnormal myocardial fiber morphology	J:86547
	cardiac hypertrophy	J:86547
	decreased body size	J:86547
	perinatal lethality, incomplete penetrance	J:86547
	thick epidermis	J:86547